ScienceDex / Researcher record
Stevens, Misty Ward
- Intervexion Therapeutics, LLC (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- Top 10% Funded
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2022 | $3,364,883 | 2 | #1,443 |
| 2023 | $4,336,347 | 1 | #954 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2022 · selected2 records
- FY20231 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Stevens, Misty Ward as a PI. Multi-PI records show the full award amount for context.
- 5U01DA051078-03U01Contact PIOptimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization$2.1Maward amount
- 1U01DA056240-01U01Contact PIIND-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder$1.2Maward amount
Award organization
Organizations that administered FY2022 awards listing Stevens, Misty Ward as a PI.
FY2022 award administered by Intervexion Therapeutics, LLC (AR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardIntervexion Therapeutics, LLC
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #1443
- 2022Entered Top 25% NationallyRanked #1443
- 2022Entered Top 10% NationallyRanked #1443
- 2023$5M Cumulative Funding
- 2023Entered Top 5% NationallyRanked #954